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Abstract: Guidance about integration of comprehensive hepatitis C virus
(HCV)-related services in sexually transmitted disease (STD) clinics is limited.
We evaluated a federally funded HCV testing and linkage-to-care program at
an STD clinic in DurhamCounty, North Carolina. During December 10, 2012,
to March 31, 2015, the program tested 733 patients for HCV who reported
1 or more HCV risk factor; 81 (11%) were HCV-infected (ie, HCVantibody-
positive and HCV ribonucleic acid-positive). Fifty-one infected patients
(63%) were linked to care. We concluded that essential program resources
include reflex HCV ribonucleic acid testing; a dedicated bridge counselor
to provide test results, health education, and linkage-to-care assistance;
and referral relationships for local HCV management and treatment.
An estimated 3.5 million persons in the United States havechronic hepatitis C virus (HCV) infection, which can progress
to cirrhosis, liver cancer, and death—yet only about half of those
living with chronic HCVare aware of their status.1,2 The Centers
for Disease Control and Prevention (CDC) recommends HCV
testing for high-risk populations, including persons who have
ever injected drugs, are human immunodeficiency virus (HIV)-
infected, or born between 1945 and 1965 (“baby boomers”).3
Because local health department (LHD) sexually transmit-
ted disease (STD) clinics serve populations at high risk for HCV
infection, targeted testing performed at STD clinics might be an
effective strategy for identification of HCV-infected persons in
the community.4–7 However, HCV-infected persons often need
specialty care for management—a resource that most LHDs lack.8
Resources are also limited for integrating comprehensive viral
hepatitis services in STD clinics, including prevention education,
testing, and linkage to care for HCV treatment.4
Among residents of DurhamCounty, the sixth largest county
in North Carolina (NC), there are barriers to viral hepatitis testing
and treatment, including health care costs, lack of transportation,
and disease stigma.9 In December 2012, the Durham County
Department of Public Health implemented an HCV testing
and linkage-to-care program funded by CDC, called HepTLC
(Hepatitis C Testing and Linkage to Care), which operated in
multiple sites throughout Durham County, including the county’s
STD clinic, the county jail, a health care for the homeless clinic,
and community testing sites.10,11 As a public health program,
the primary goal of HepTLC was to identify HCV-infected (ie,
HCV antibody-positive and HCV ribonucleic acid (RNA)-positive)
persons in the community and link those persons to care; the
program was not designed or resourced to follow up patients
through the HCV care cascade. We specifically evaluated the
HepTLC program at the county’s STD clinic to (1) demonstrate
the effect of targeted HCV testing on infection-status awareness
and linkage to care among HCV-infected persons; and (2) identify
essential resources needed for integrating HCV-related services
in this practice setting.
MATERIALS AND METHODS
Program Activities and Resources
The Durham County STD Clinic evaluates approximately
4500 patients annually for STD-related conditions and provides re-
ferral for immunizations, substance abuse, mental health counseling
and primary care services in the community. There are no costs
incurred by patients for any of the services provided. As part of
the HepTLC program, all STD clinic patients completed a self-
assessment form during the clinic visit, including demographics
and HCV risk factors.3,4 The HCV risk factors included the fol-
lowing: HIV-positive, ever injected drugs, born between 1945
and 1965 (baby boomers), ever received hemodialysis, received
an organ transplant or blood transfusion before 1992, received
an unregulated tattoo, ever incarcerated, sex with a person who
has ever injected drugs; sex with an HCV-infected person, ever re-
ceived a diagnosis of syphilis, ever exchanged sex for money
or drugs, >3 sexual partners in the 60 days before HCV testing,
and men who have sex with men. Patients reporting ≥1 of these
HCV-related risk factor were offered HCV testing at no charge.
Additionally, patients who self-reported a previous HCV-positive
result and requested testing through the HepTLC program were
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provided testing, because clinicians had no means of verifying
previous results. Specimens were collected for HCV antibody
and reflex RNA testing (ie, automatic confirmatory testing for
positive antibody results) and transported to a local hospital labo-
ratory for analyses.4,12
Patients were asked to return to the clinic within 2 weeks of
testing, at which time health educators or an HCV bridge coun-
selor provided test results and, among HCV-infected (ie, HCV
antibody-positive and HCV RNA-positive) patients, referrals for
combination hepatitis A/B vaccinations at the LHD. The primary
role of the HCV bridge counselor was to assist these HCV-
infected patients with linkage to care. The bridge counselor also
provided additional posttest counseling, including guidance for
liver protection and testing recommendations for sexual partner
(s). The bridge counselor attempted to contact HCV-infected pa-
tients who did not return for their results through a minimum of
2 telephone calls, 2 letters, and a home visit.
Two academic medical centers, the University of North
Carolina at Chapel Hill (Chapel Hill, NC) and Duke University
(Durham, NC), participated in the HepTLC program as referral
sites. The bridge counselor referred HCV-infected patients to the
patient’s choice of health care provider. In November 2013, a
biweekly onsite HCV clinic at the LHD was also established,
providing the opportunity for HCV-infected patients to be referred
to either the onsite clinic or to one of the academic medical
centers. Initial medical evaluations were provided regardless of
patient insurance status at all locations. As an incentive to attend
their initial appointment, two bus passes and a US $10 gift card
were provided to each referred patient.
The HepTLC budget for program implementation in Dur-
ham County was approximately US $200,000 per year for 2 years
(December 2012 to December 2014), with a no-cost award exten-
sion through March 2015. Approximately 25% (US $50,000) of
yearly project funds were directed toward HepTLC activities at the
STD clinic, which included the costs of HCV testing; data collec-
tion; and staffing (project coordination, phlebotomist, and bridge
counselor), who also supported other testing locations.
Program Evaluation
We identified the components of the HepTLC program at
the STD clinic and developed a logic model on the basis of stake-
holder interviews and program documentation (see Supplemen-
tal Digital Content, logic model, http://links.lww.com/OLQ/
A214 ).13 We used the program’s patient database for the period
of December 10, 2012, to March 31, 2015, to characterize the
population tested for HCV, including demographics, risk factors,
and test results.3,4 We compared patient demographics (self-
reported race [white and nonwhite], sex (female and male], and
age category [≤40 years and ≥41 years]) by HCV status using
χ2 tests (α=0.05). Among HCV-infected patients, we estimated
the proportion linked to care, which was defined as attending
an initial appointment for medical evaluation of their HCV infec-
tion.10 We compared the number of patients linked to care at an
onsite HCV clinic with the number linked to care at local aca-
demic medical centers to assess patient preference for referral.
An online survey of all STD clinic providers (3 nurse practi-
tioners, 2 nurses, and 2 health educators) was implemented to
identify barriers and solutions related to integrating HCV testing
in the clinic.
Human Participant Compliance
This evaluation was reviewed by CDC for human subject
protection and designated as public health practice and not subject
to institutional review board review.
RESULTS
Testing Population and Linkage to Care
From December 10, 2012, to March 31, 2015, a total of
8431 patients were evaluated at the STD clinic and 733 unique, in-
dividual patients (9%)met the criteria for targetedHCV testing. Of
these, 480 (66%)were men, 507 (69%)were black, and 370 (51%)
were from the “baby boomer” birth cohort. Twenty-seven (4%) pa-
tients were HCVantibody-positive and HCV RNA-negative, indi-
cating previous, resolved infection, and 81 (11%) were positive
for both HCV antibody and RNA, indicating chronic infection
(Table 1). Seventy-eight (11%) patients received HCV antibody
testing on more than 1 occasion during the evaluation period.
Among the 81 unique HCV-infected patients, 58 (72%)
were men, 51 (63%) were black, and 58 (72%) were birth cohort
members. Statistically significant associations with HCV status
were found for patient self-reported race (P<0.001) and for pa-
tient age category (P<0.001) but not for patient sex (P=0.2). The
highest proportion of HCV infections were detected among pa-
tients who reported ever injecting drugs (49 [52%] of 95 ), whereas
a lower proportion of HCV infectionswere observed among “baby
boomers” (58 [16%] of 370). Among HCV-infected patients, 6
(7%) did not report a risk factor as defined by CDC guidelines;
5 of these patients underwent HCV testing on the basis of having
ever been incarcerated or having a tattoo, and 1 patient reported no
risk factors.
Of the HCV-infected patients, 51 (63%) were linked to care
through the program. The 30 patients (37%) not linked to care
were persons who were incarcerated, refused services, or could
not be located. Of those patients linked to care, 34 (67%) patients
attended the health department’s onsite HCV clinic and 17 (33%)
patients attended their appointments at an academicmedical center
clinic. After the onsite HCV clinic was established in November
2013, only 4 (8%) of patients linked to care attended the initial
medical evaluation at a local academic medical center clinic.
Survey of STD Clinic Staff
Five (71%) of 7 STD clinic staff responded to the online
survey. Respondents reported that HCV testing activities hadminimal
effect on the clinic workflow, but added an estimated 10minutes to
each patient interaction. Per all respondents, reflex HCV RNA
testing maintained clinic efficiency by eliminating a return visit
by patients for a second blood draw. All respondents indicated that
knowledge of local HCV management and treatment resources
with HCV specialists was a critical component for successful linkage
to care. Furthermore, respondents indicated that the HCV bridge
counselor eased program implementation by providing HCV test
results, education messages, and patient navigation services.
CONCLUSIONS
During the evaluation period, the Durham County STD
clinic successfully implemented an HCV testing and linkage-to-
care program, as evidenced by an increased number of HCV-
infected persons whowere aware of their HCV status and attended
their first medical evaluation appointment. The HCV infection
prevalence of 11% among the tested population, comparable to a
recent study in a similar setting, supports the need for integrated
HCV services in the STD clinic setting.14
The distribution of HCV risk factors reported by the infected
population is consistent with the established epidemiology.2,3 Al-
though STD clinics should follow established, risk factor-based
HCV testing guidelines, knowledge of local HCV epidemiology
and the clinic's target population could inform expanded testing.
evaluation of HCV infection; however, comprehensive informa-
tion is not available regarding reasons for not being linked to care
or regarding subsequent HCV treatment initiation or outcomes.
Only 5 (71%) of 7 STD clinic staff responded to the online survey,
limiting conclusions about program sustainability. Finally, find-
ings from this evaluation might be most relevant to LHDs with
similar size and resources as the DurhamCounty STD clinic. Rep-
licability of this program to other LHDs might also be limited by
available funding.
Policy and Practice Implications
Local health department STD clinics serve populations at
high risk for HCV infection. The HCV-related services, including
prevention education, testing, and linkage to care, can be success-
fully integrated into STD clinic activities. Because cost must be
considered when planning integrated services, program priorities
should include laboratory resources to provide reflex HCV RNA
testing; a dedicated HCV bridge counselor to provide test results,
health education, and linkage-to-care assistance; and the establish-
ment of local and accessible health care providers for HCV referral
and management.
TABLE 1.Characteristics of Patients Tested for HCV Infection at a STD Clinic—DurhamCounty, North Carolina, December 10, 2012, toMarch
31, 2015
Characteristics HCV-Infected,* n = 81 (%) Not HCV-Infected,† n = 652 (%) Total, N = 733
Race/ethnicity (self-identified)
Black 51 (10) 456 (90) 507
White 27 (19) 115 (81) 142
Hispanic 0 (0) 51 (100) 51
Other 1 (7) 14 (93) 15
Missing 2 (11) 16 (89) 18
Sex
Male 58 (12) 422 (88) 480
Female 22 (9) 223 (91) 245
Transgender 0 (0) 5 (100) 5
Missing 1 (33) 2 (67) 3
Age, y‡
<21 0 (0) 39 (100) 39
21–40 17 (7) 238 (93) 255
41–60 56 (15) 323 (85) 379
>60 8 (14) 49 (86) 57
Missing 0 (0) 3 (100) 3
Risk factors§
Multiple sexual partners 14 (7) 190 (93) 204
Injection drug use 49 (52) 46 (48) 95
Sex with injection drug user 16 (21) 60 (79) 76
Recent syphilis diagnosis¶ 3 (3) 114 (97) 117
Sex with HCV-positive partner 8 (23) 27 (77) 35
Hemodialysis|| 0 (0) 1 (100) 1
Blood transfusion before 1992 2 (6) 34 (94) 36
Tattoo 40 (16) 207 (84) 247
Men who have sex with men 1 (1) 90 (99) 91
Ever received money or drugs for sex 13 (20) 53 (80) 66
Ever incarcerated 55 (25) 166 (75) 221
HIV-positive 1 (4) 26 (96) 27
Born between 1945 and 1965 (baby boomers) 58 (16) 312 (84) 370
No identified risk factors 0 (0) 4 (100) 4
Missing 2 (18) 9 (82) 11
*Evidence of active HCV infection (HCVantibody-positive and HCV ribonucleic acid-positive).
†No evidence of HCV infection (HCV antibody-negative) or evidence of resolved HCV infection (HCV antibody-positive and HCV ribonucleic
acid-negative).
‡Age at first HCV testing at Durham County Department of Public Health during December 10, 2012, to March 31, 2015.
§>1 risk factor per individual is possible.
¶Defined as a diagnosis of syphilis within the past 12 months of HCV test date.
||Defined as having ever received chronic hemodialysis.
Evaluation findings demonstrate that HCV testing and 
linkage-to-care services can be successfully integrated into rou-
tine STD clinic activities. However, a number of essential re-
sources are required. First, partnering with a laboratory to 
perform reflex HCV RNA testing eliminates the need for 
HCV antibody-positive patients to return for a second blood 
draw. Second, a dedicated bridge counselor facilitates compre-
hensive HCV services and assists patients in the logistics of 
linkage to care (eg, transportation) without impacting existing 
clinic workflows. Third, STD clinic efforts to integrate services 
should consider the referral preferences of their target popula-
tion and partner with easily accessible providers (eg, federally 
qualified health centers) in the nearby area.15 Most HCV-
infected patients (67%) linked to care through the HepTLC 
program selected referral to the onsite HCV clinic for their ini-
tial medical evaluation, indicating a preference to return to the 
LHD for medical care.
This evaluation entailed multiple limitations. HCV risk fac-
tors were self-reported and might not represent actual infection 
risk. A record of refusals was not maintained; therefore, an HCV 
testing participation rate cannot be determined. Linkage to care 
was defined as attending an initial appointment for medical
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